Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by KAMINSKI, N. E.
Right arrow Articles by HOLSAPPLE, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by KAMINSKI, N. E.
Right arrow Articles by HOLSAPPLE, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1989 Oxford University Press

research-article

Suppression of Humoral Immune Responses by Dialkylnitrosamines: Structure-Activity Relationships1

NORBERT E. KAMINSKI*, STEPHEN D. JORDAN*, DENNIS PAGE{dagger}, BYUNG SAM KIM{ddagger} and MICHAEL HOLSAPPLE*

*Department of Pharmacology and Toxicologyy. Medical College of Virginia/Virginia Commonwealth University Richmond, Virginia 23298 {dagger}Department of Oral Patho1og.v. Medical College of Virginia/Virginia Commonwealth University Richmond, Virginia 23298 {ddagger}Department of Biological Sciences and Engineering. Korea Advanced institute of Science and Technology Seoul. Korea

Received February 17, 1988; accepted July 18, 1988

Suppression of Humoral Immune Responses by Dialkylnitrosamines: Structure-Activity Relationships. KAMINSKI, N. E., JORDAN, S. D., PAGE, D., KIM, B. S., AND HOLSAPPLE, M. P. (1989). Fundam. Appl Toxicol 12,321-332. Comparisons between chemical structure of N, N-dialkylnitrosamine congeners and their ability to alter the Day 4 IgM antibody response to sRBC, body weights. and organ weights of female B6C3F1 mice were investigated. Short-chain nitrosamine congeners were selected for these studies on the basis of two criteria: (1) congeners wth symmetrical aliphatic chain length [N-nitrosodimethylamine (DMN), N-nitrosodiethylamine (DEN), N-nitrdipropylamine (DPN), N-nitrosodibutylamine (DBN)] and (2) congeners possessing an N-methyl group [N-nitrosomethylethylamine (MEN), N-nitrosomethylpropylamine (MPN), and N-nitrosomethylbutylamine (MBN)]. The immunotoxicity of each congener was evaluated based on the compound's ability to suppress the in vivo sRBC antibody response following 7 consecutive days of treatment. An ED50 dose was calculated, using a linear regression analysis, for each congener and represents the millimoles of congener per kilogram body weight required to cause a 50% suppression of the sRBC response. These studies demonstrated two general trends: (1) those dialkylnitrosamine congeners that possessed an N-methyl group were most immunotoxic and exhibited comparable ED50 concentrations (42-183 µmol/kg); and (2) dialkylnitrosamine congeners possessing symmetrical aliphatic chains demonstrated an inverse relationship between aliphatic chain length and immunotoxic potency—DMN (62 µmol/kg) > DEN (276 µmol/kg) > DPN (467 µmol/kg) > DMN (1557 µmol/kg). Comparisons were also made between the immunotoxic potency of various nitrosamine congeners in the whole animal and their potency in an in vitro hepatocyte-spleen cell coculture system.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.